Active Ingredient(s):Betaxolol FDA Approved: * August 30, 1985 Pharm Company: *ALCON Category:Blood Pressure
Betaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affinity for beta1 receptors than metoprolol. In addition to its effect on the heart, betaxolol reduces the pressure within the eye (intraocular pre...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion